- Home
- BMRN vs FLS Comparison
BMRN vs FLS Comparison
Compare BMRN & FLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | FLS |
|---|---|---|
| Founded | 1996 | 1790 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 9.9B |
| IPO Year | 1999 | 2006 |
Fundamental Metrics
Financial Performance| Metric | BMRN | FLS |
|---|---|---|
| Price | $58.53 | $74.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 10 |
| Target Price | ★ $87.24 | $85.20 |
| AVG Volume (30 Days) | ★ 2.1M | 1.5M |
| Earning Date | 05-21-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.16% |
| EPS Growth | N/A | ★ 23.36 |
| EPS | 1.80 | ★ 2.64 |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $13.34 | $6.95 |
| Revenue Next Year | $11.42 | $6.09 |
| P/E Ratio | $32.80 | ★ $28.64 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $50.76 | $37.34 |
| 52 Week High | $73.18 | $92.41 |
Technical Indicators
Market Signals| Indicator | BMRN | FLS |
|---|---|---|
| Relative Strength Index (RSI) | 42.57 | 31.83 |
| Support Level | $56.08 | $69.08 |
| Resistance Level | $60.52 | $92.41 |
| Average True Range (ATR) | 2.25 | 2.79 |
| MACD | -0.41 | -1.70 |
| Stochastic Oscillator | 1.80 | 0.82 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About FLS Flowserve Corporation
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.